AI-Powered Eye Scan Slashes Diagnosis Time from Weeks to Seconds!

Taiwan-based Acer Medical’s artificial intelligence-assisted diagnostic software and a combination of Intel hardware- and software-based technology, is making eye lesion detection dramatically faster, said Acer Medical, a subsidiary of Acer group in an official blog post.

Traditionally, diagnosing conditions like diabetic retinopathy or age-related macular degeneration could take weeks, especially when multiple specialists were involved. Now, thanks to Acer Medical’s AI-assisted diagnostic software running on Intel-backed AI PCs, results can be delivered in seconds.

The system uses high-resolution fundus photography to scan the inner eye, with AI algorithms analyzing images instantly. This eliminates the need for dilation-related eye drops and long wait times. The AI PC processes everything locally, meaning no internet connection is required—making it ideal for remote healthcare.

 

Dr. Hsieh Yi-Ting (foreground) demonstrates detailed eye scans of a patient on his Acer Travelmate Spin P4 AI PC, connected to a high-resolution fundus camera. Thanks to AI algorithms developed using Intel OpenVINO tool kits, the medical team sees results in just 10 seconds. (Image Credit: Intel Corporation)

Results are processed using Acer Medical’s VeriSee DR for diabetic retinopathy and VeriSee Age-related Macular Degeneration (VeriSee AMD) for age-related macular degeneration.

Created by Acer Medical in partnership with medical specialists, the technology is available in 13 countries.

Dr. Hsieh Yi-Ting, a retina specialist at National Taiwan University Hospital, developed the VeriSee DR and VeriSee AMD solutions, which are now available in 13 countries. These tools help doctors prioritize cases and expedite treatment, but they don’t replace medical professionals—rather, they enhance their ability to provide faster, more accurate care.

Acer Medical is a subsidiary of the Acer Group specializing in AI-driven medical diagnostics. They focus on leveraging artificial intelligence, clinical data, and software development to create healthcare solutions. The company's technology has been implemented in over 300 hospitals and clinics, serving an estimated 450,000 patients annually.

Their AI-powered tools, like VeriSee DR and VeriSee AMD, help detect eye diseases such as diabetic retinopathy and age-related macular degeneration in seconds, significantly reducing diagnosis time.

 
This AI-driven approach is a game-changer for rural healthcare, allowing specialists to diagnose patients far from hospitals. What do you think about AI’s expanding role in medicine? Do comment your opinion below...

Indian Ophthalmologist Performs Asia’s First AI-Designed Intraocular Lens Implantation

Dr. Sri Ganesh, Founder and CMD of Nethradhama, became the first surgeon in Asia to carry out the procedure, which helps cataract and astigmatism patients achieve clear vision across all distances with reduced dependence on glasses.

Nethradhama Super Speciality Eye Hospital, Bengaluru, a pioneering institution in eye care, has performed Asia’s first AI-designed intraocular lens implantation. Under the leadership of Professor Dr. Sri Ganesh, Chairman & Managing Director of Nethradhama Super Speciality Eye Hospital and Founder Trustee of Shraddha Eye Care Trust, the hospital achieved this milestone, making him the first surgeon in Asia to carry out the procedure using Rayner RayOne Galaxy and Galaxy Toric intraocular lenses (IOLs).

“Our goal is always to provide the best solutions for our patients, and this innovation allows us to offer superior vision outcomes with minimal side effects,” said Dr. Sri Ganesh. “By leveraging AI-driven technology in intraocular lens design, we can achieve greater precision, enhanced customization, and improved patient satisfaction.”

This represents a notable advancement in AI-driven vision correction and a significant step forward in refractive cataract surgery, bringing us closer to more personalized vision solutions.

“The biggest challenge with previous IOLs has been balancing vision quality with night vision clarity,” explained Dr. Sri Ganesh. “This new lens overcomes this by using AI to optimize light distribution, giving patients an exceptional visual experience. It revolutionizes vision with its non-diffractive, AI-optimized spiral design, ensuring seamless clarity at all distances while enhancing contrast sensitivity. Unlike traditional trifocal lenses, it evenly distributes light across all focal points, reducing halos and glare for improved night vision. Its innovative optical structure enhances contrast even in low light, and the toric variant offers optimal rotational stability for precise astigmatic correction."

Dr. Sri Ganesh 

These lenses are specifically designed for patients with cataracts and astigmatism who seek reduced dependence—or complete independence—from glasses.

“For our patients, achieving true spectacle independence has always been a priority. They are particularly beneficial for individuals who require excellent vision across all distances while maintaining good night vision for driving and other low-light activities,” noted Dr. Sri Ganesh.

According to Dr. Sri Ganesh, the initial post-operative results have been extremely promising, with patients reporting excellent visual clarity within the first 24 hours. He added that long-term studies will continue to assess patient-reported experiences, particularly in real-world conditions like night driving and low-light environments.

Dr. Sri Ganesh is widely recognized for his expertise in high-risk surgeries, earning a stellar reputation in the field of advanced eye care. With an impeccable track record, he has performed over 100,000 Phaco surgeries and 50,000 Refractive surgeries, demonstrating exceptional surgical precision and innovation. His expertise is highly sought after on the global stage, serving on the advisory boards of leading companies such as Carl Zeiss Meditec Germany and J&J Vision USA. Beyond surgery, he has played a pivotal role in ophthalmic innovation, holding multiple patents for groundbreaking solutions that continue to shape the future of eye care.

To ensure an informed decision-making process, Nethradhama Super Speciality Eye Hospital offers comprehensive counseling and visual simulation sessions for patients considering these AI-designed IOLs. These sessions allow patients to preview their expected vision outcomes, including night vision improvements.

“With AI-driven advancements like these, we are witnessing a paradigm shift in ophthalmology. Our mission at Nethradhama Super Speciality Eye Hospital is to continually push the boundaries of innovation to provide our patients with the best possible visual outcomes. We are thrilled to bring this revolutionary technology to Asia and look forward to its impact on the future of vision correction,” added Dr. Sri Ganesh

Under Dr. Sri Ganesh’s leadership, Nethradhama is committed to innovation and excellence, continuously integrating state-of-the-art technologies to ensure the best possible visual outcomes for patients. Through its dedication to research, training, and compassionate care, it has established itself as a trusted name in eye health, both in India and globally.